Ready for a rapid, radical reboot of the global innovation system for a truly free and open 21st century knowledge economy?
The Open Science Summit is an attempt to gather all stakeholders who want to liberate our scientific and technological commons and enable a new era of decentralized, distributed innovation to solve humanity's greatest challenges.
Dr. Barry Bunin, CEO & President of Collaborative Drug Discovery Inc.
(www.collaborativedrug.com) helps scientists in secure collaborative groups more rapidly
develop drug candidates for commercial and humanitarian markets. Thousands of researchers
worldwide use CDD today. Dr. Bunin and CDD received funding in 2008 to support a
global community of leading TB researchers from the Gates Foundation (BMGF). He co-
authored “Chemoinformatics: Theory, Practice, and Products”, a text that overviews modern
chemoinformatics technologies and “The Combinatorial Index”, a widely used text on high-
throughput chemical synthesis. Dr. Bunin was an Entrepreneur-in-Residence at Eli Lilly and the
founding CEO, President, & CSO of Libraria. In the lab, Dr. Bunin did medicinal chemistry
developing patented new chemotypes for protease inhibition at Axys Pharmaceuticals and RGD
mimics to inhibit GP-IIbIIIa at Genentech. Dr. Bunin is on a patent for Carfilzomib – a selective
proteasome inhibitor now in phase 3 clinical trials for multiple myeloma. Dr. Bunin received his
Ph.D. at Berkeley, where he synthesized and tested the initial 1,4-benzodiazepine libraries with
Professor Jonathan Ellman.
Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science. He is a Distinguished Researcher with Autodesk Inc.’s Bio/Nano Programmable Matter group, based out of San Francisco. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.
Professor Izant is the Vice President and COO of Sage Bionetworks. Prior to this he held positions as Deputy Director Global Health Operations at the Bill and Melinda Gates Foundation and Adjunct Professor at the Centre for Philanthropy and Nonprofit Studies at Queensland University of Technology.
Professor Izant has extensive Australian and international experience in academic research, pharmaceutical corporation product development, as well as public sector technology transfer including building and leading biotech spin-off companies. He has held senior positions at the Institute of Health and Biomedical Innovation, National Health and Medical Research Council Human Gene Advisory, Queensland Biotechnology Advisory Council; Head, Health & Medical Working Group, and e-Health Research Centre Advisory Committee.
Professor Izant has also held positions on the NH&MRC Development Grant Assessment Panel and New South Wales Health BioFirst Awards Committee.